Alto Neuroscience, Inc.
ANRO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14 | -$18 | -$15 | -$15 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2 | $2 | $2 |
| Change in WC | $1 | $1 | -$5 | $0 |
| Other Non-Cash | $3 | $0 | $1 | $0 |
| Operating Cash Flow | -$10 | -$14 | -$17 | -$13 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$0 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $1 | $9 | $0 |
| Stock Issued | $0 | -$1 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$1 | $0 |
| Financing Cash Flow | $0 | $1 | $9 | $0 |
| Forex Effect | -$0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | -$10 | -$13 | -$7 | -$13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $148 | $161 | $169 | $182 |
| End Cash | $138 | $148 | $161 | $169 |
| Free Cash Flow | -$10 | -$14 | -$17 | -$14 |